Diagnostyka

Diagnostyka FCF Yield

The Free Cash Flow Yield of Diagnostyka (DIA.WA) as of Oct 27, 2026 is 5.64 %. In the previous year, Free Cash Flow Yield was 4.59 % — a change of 22.73% (higher).

FCF Yield

5.64 %

YoY

22.73%

Last updated:

Free Cash Flow Yield of Diagnostyka is 2025 5.64 % . Free Cash Flow Yield of Diagnostyka was 2024 4.59 % . It decreases by 22.73% higher compared to the previous year.

The Diagnostyka FCF Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Yield
Date
FCF Yield
Jan 1, 2021
9.86 PLN
Jan 1, 2022
3.16 PLN
Jan 1, 2023
4.14 PLN
Jan 1, 2024
4.59 PLN
Jan 1, 2025
5.64 PLN
The Diagnostyka FCF Yield history
YEARFCF YieldYoY
5.64 %+22.73%
4.59 %+11.02%
4.14 %+30.92%
3.16 %-67.95%
9.86 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Diagnostyka Stock analysis

What does Diagnostyka do? Diagnostyka SA generates revenue through its network of 180 laboratories and 1,100 Sampling Labs across Poland, offering over 3,000 test types including hematology, infection diagnostics, allergology, and hormonal diagnostics. The company provides both routine and specialist laboratory services, with tests available with or without a physician's referral, catering to individual patients and healthcare providers. Its specialization in molecular biology, autoimmune diagnostics, and blood collection drives demand from private individuals seeking direct access to medical analysis without a doctor's prescription. The firm's revenue model relies on a comprehensive service chain from biological material collection and transportation to final analysis results, serving a broad customer base including patients, clinics, and hospitals. With a focus on accessible diagnostics, Diagnostyka SA expands its market reach through its extensive lab network, enabling widespread availability of medical testing services throughout Poland. The company's ability to deliver specialized tests like molecular biology and autoimmune diagnostics differentiates its offerings in the healthcare sector. Diagnostyka is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Diagnostyka stock

Free Cash Flow Yield of Diagnostyka is 5.64 % in 2025.

Free Cash Flow Yield of Diagnostyka changed from 4.59 % to 5.64 %, representing a 22.73% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Yield Diagnostyka since 2006 – with annual values, charts, and detailed analysis.

FCF Yield measures the free cash flow per share relative to the stock price. It indicates how much cash a company generates for each dollar invested.

To evaluate Free Cash Flow Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Yield's Diagnostyka with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Diagnostyka

All Key Metrics — Diagnostyka